Intrarosa
My Prescription
Payment
Select pharmacy
$323.75
Print or send this coupon to your phone
AlbertsonsPowered byAbout Intrarosa
Drug Details
Intrarosa (prasterone) is a vaginal insert designed for postmenopausal women experiencing painful intercourse, a condition often due to the thinning, drying, and inflammation of vaginal walls. This medication is a synthetic form of dehydroepiandrosterone (DHEA), a hormone naturally produced by the body. Although the precise mechanism is not fully understood, it is believed that the body converts prasterone into estrogens and androgens, hormones that can help rejuvenate vaginal tissue and improve lubrication, thus alleviating pain during sexual activity. Intrarosa is applied once daily at bedtime. A common side effect is vaginal discharge. Currently, no generic version of this medication is available. Always consult your healthcare provider before starting any new treatment.
Price history for Intrarosa
28 Inserts, 6.5MG
Average retail price for Intrarosa
Average SaveHealth price for Intrarosa
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Intrarosa dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 6.5MG | 28 Inserts | $323.95 | $11.57 |
Intrarosa FAQs
Intrarosa is used for the treatment of moderate to severe dyspareunia, which is pain during sexual intercourse, a symptom of vulvar and vaginal atrophy due to menopause. It contains prasterone, which is a synthetic form of dehydroepiandrosterone (DHEA), and helps alleviate symptoms by being converted into estrogen and androgens in the body.
Intrarosa (prasterone) is not known to significantly increase systemic estrogen levels. It is a vaginal insert used to treat moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause. It works locally in the vaginal tissues and is not associated with a significant increase in circulating estrogen levels.
The choice between Intrarosa (prasterone) and estradiol for treating symptoms of vulvovaginal atrophy in postmenopausal women depends on individual patient needs, preferences, and medical history. Intrarosa is a non-estrogen treatment that may be preferred for those who wish to avoid estrogen. Estradiol, on the other hand, is an estrogen-based treatment that may be more effective for some individuals. It is important for patients to discuss with their healthcare provider to determine the most appropriate treatment option based on their specific circumstances.
Intrarosa (prasterone) is used to treat moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause. Clinical studies have shown that Intrarosa can be effective in reducing the severity of dyspareunia by improving vaginal tissue condition. However, individual responses to the treatment may vary, and it is important for patients to discuss with their healthcare provider to determine if it is the right option for them.
Intrarosa should not be used by individuals who have undiagnosed abnormal genital bleeding, known or suspected breast cancer, or any other estrogen-dependent neoplasia. Additionally, it should be avoided by those with a known hypersensitivity to any of its components. It is important for individuals to consult with their healthcare provider to determine if Intrarosa is appropriate for their specific medical condition.